About Avata Biosciences
Avata Biosciences is a company based in New York (United States) founded in 2023. It operates as a B2B and Research and Development. Avata Biosciences offers products and services including AVAT-021 Capsule, AVAT-022 Aqueous Solution, AVAT-031 Solid Dose, and AVAT-041 Solid Dose. Avata Biosciences operates in a competitive market with competitors including Skye Bioscience, GW Pharma, IGC Pharma, MIRA Pharmaceuticals and NEUROPATHIX, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Avata Biosciences
Avata Biosciences offers a comprehensive portfolio of products and services, including AVAT-021 Capsule, AVAT-022 Aqueous Solution, AVAT-031 Solid Dose, and AVAT-041 Solid Dose.
Capsule formulation for treating adult focal epilepsy.
Water-soluble solution for neurological disease management.
Solid dose preparation for pediatric focal epilepsy.
Solid dose for schizophrenia and opioid sparing.
Funding Insights of Avata Biosciences
Detailed funding history for Avata Biosciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Avata Biosciences
Investment portfolio details for Avata Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Avata Biosciences
Detailed financials for Avata Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Avata Biosciences Comparisons
Peer comparison for Avata Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Avata Biosciences
Avata Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Skye Bioscience, GW Pharma, IGC Pharma, MIRA Pharmaceuticals and NEUROPATHIX, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cannabinoid-based therapies for glaucoma and other diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of cannabinoid medicines for MS spasticity, cancer pain and childhood epilepsy
|
|
| Locked | Locked | Locked |
Pharmaceutical products targeting neurological disorders like Alzheimer's are developed.
|
|
| Locked | Locked | Locked |
Cannabinoid-based therapeutics for chronic pain and anxiety are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics targeting inflammation, neurodegeneration, oxidative stress, and neuropathic pain
|
|
| Locked | Locked | Locked |
Cannabis-based therapeutics are developed for pain and neurological disorders.
|
Detailed competitors of Avata Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Avata Biosciences
Complete news archive for Avata Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avata Biosciences
Avata Biosciences was founded in 2023.
Avata Biosciences is headquartered in New York, United States. It is registered at New York, New York, United States.
Avata Biosciences is a clinical-stage pharmaceutical company that combines synthetic cannabinoids with a novel formulation process to create medicines for neurological conditions. It focuses on improving bioavailability and scalability in manufacturing, targeting underserved patient populations. The company partners with institutions like Oxford University for research in mental health. Based in locations including the United States and United Kingdom, it advances programs through preclinical and clinical stages for diseases such as epilepsy and schizophrenia.
Avata Biosciences's top competitors include IGC Pharma, MIRA Pharmaceuticals and GW Pharma.
Avata Biosciences offers AVAT-021 Capsule, AVAT-022 Aqueous Solution, AVAT-031 Solid Dose, and AVAT-041 Solid Dose.